Drug Shortage Report for APO-SUCRALFATE - TAB 1G
| Report ID | 169045 |
| Drug Identification Number | 02125250 |
| Brand name | APO-SUCRALFATE - TAB 1G |
| Common or Proper name | SUCRALFATE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUCRALFATE |
| Strength(s) | 1G |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | A02BX |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-06 |
| Estimated end date | 2023-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-05-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v26 | 2023-05-12 | French | Compare |
| v25 | 2023-05-12 | English | Compare |
| v24 | 2023-04-21 | French | Compare |
| v23 | 2023-04-21 | English | Compare |
| v22 | 2023-03-23 | French | Compare |
| v21 | 2023-03-23 | English | Compare |
| v20 | 2023-03-02 | French | Compare |
| v19 | 2023-03-02 | English | Compare |
| v18 | 2023-02-23 | French | Compare |
| v17 | 2023-02-23 | English | Compare |
| v16 | 2023-01-26 | French | Compare |
| v15 | 2023-01-26 | English | Compare |
| v14 | 2023-01-20 | French | Compare |
| v13 | 2023-01-20 | English | Compare |
| v12 | 2022-12-16 | French | Compare |
| v11 | 2022-12-16 | English | Compare |
| v10 | 2022-11-20 | French | Compare |
| v9 | 2022-11-20 | English | Compare |
| v8 | 2022-11-11 | French | Compare |
| v7 | 2022-11-11 | English | Compare |